Executive record

John P. Sharp

John P. Sharp holds the CFO seat at Cadrenal Therapeutics, Inc. on the record, Interim Chief Financial Officer, effective June 25, 2026.

1 verified record · 1 company · current seat on the record: Cadrenal Therapeutics, Inc.

Career line from the records

1

Each seat as a filing states it, newest first. Titles appear only as the filing prints them for this person.

  1. 2026-06-29InterimCadrenal Therapeutics, Inc.current seat

    Cadrenal Therapeutics, Inc. names John P. Sharp interim CFO

    Named as the incoming officer, Interim Chief Financial Officer

    effective June 25, 2026 · 8-K filed June 29, 2026 · sec.gov, Item 5.02

Companies

1

Cadrenal Therapeutics, Inc.CVKD

Pharmaceutical Preparations

This page lists only verified filing records that name John P. Sharp, matched by the name as the filings print it; it is not a career history. Corrections: the corrections page.